Nutritional and Metabolic Diseases: News and Research on Overweight

MeSH tree: C18.654.726.750

New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...

Age limits alone won't fix smartphone risks, suggests study

Researchers at Children's Hospital of Philadelphia (CHOP), in collaboration with the University of California, Berkeley, and the University of Pennsylvania Perelman School of Medicine, found that a year after receiving their ...

page 11 from 40